Objective: To compare the effectiveness of various drug interventions in improving the clinical outcome of postoperative patients after aneurysmal subarachnoid hemorrhage (aSAH) and assist in determining the drugs of definite curative effect in improving clinical prognosis.Methods: Eligible Randomized Controlled Trials (RCTs) were searched in databases of PubMed, EMBASE, and Cochrane Library (inception to Sep 2020). Glasgow Outcome Scale (GOS) score, Extended Glasgow Outcome Scale (GOSE) score or modified Rankin Scale (mRS) score was used as the main outcome measurements to evaluate the efficacy of various drugs in improving the clinical outcomes of postoperative patients with aSAH. The network meta-analysis (NMA) was conducted based on a random-effects model, dichotomous variables were determined by using odds ratio (OR) with 95% confidence interval (CI), and a surface under the cumulative ranking curve (SUCRA) was generated to estimate the ranking probability of comparative effectiveness among different drug therapies.Results: From the 493 of initial citation screening, forty-four RCTs (n = 10,626 participants) were eventually included in our analysis. Our NMA results showed that cilostazol (OR = 3.35,95%CI = 1.50,7.51) was the best intervention to improve the clinical outcome of patients (SUCRA = 87.29%, 95%CrI 0.07–0.46). Compared with the placebo group, only two drug interventions [nimodipine (OR = 1.61, 95%CI 1.01,2.57) and cilostazol (OR = 3.35, 95%CI 1.50, 7.51)] achieved significant statistical significance in improving the clinical outcome of patients.Conclusions: Both nimodipine and cilostazol have exact curative effect to improve the outcome of postoperative patients with aSAH, and cilostazol may be the best drug to improve the outcome of patients after aSAH operation. Our study provides implications for future studies that, the combination of two or more drugs with relative safety and potential benefits (e.g., nimodipine and cilostazol) may improve the clinical outcome of patients more effectively.
Objective: This study aimed to develop and validate a multivariate logistic regression model for predicting intracranial aneurysm (IA) rupture by integrating clinical data, aneurysm morphology, and parent artery characteristics using high-resolution vessel wall imaging (HR-VWI).Methods: A retrospective analysis was conducted on 298 patients with 386 aneurysms. Patients were randomly divided into training (n = 308) and validation (n = 78) sets. Key predictors, including aneurysm size, shape, aneurysm wall and parent artery wall enhancement, were identified through univariate analysis and then used to build the prediction model using multivariate logistic regression. The model was visualized as a nomogram and compared to PHASES and ELAPSS scores.Results: The logistic regression model demonstrated superior predictive performance with an area under the curve of 0.814, which was significantly higher than PHASES and ELAPSS scores (p < 0.05). The model revealed strong calibration and good agreement between predicted and observed rupture probabilities.Conclusion: The multivariate model based on HR-VWI, which incorporates aneurysm and parent artery features, provides a more accurate prediction of IA rupture risk than conventional scoring systems, offering a valuable tool for clinical decision-making.